Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Robot tailored to you: new hope for stroke arm recovery?

NCT ID NCT07316218

Symptom relief Sponsor: Federico Posteraro Source: ClinicalTrials.gov ↗

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This pilot study tested a wearable robotic arm device (NESM-α) in 7 stroke survivors to see if it is safe and feasible for rehab. The robot adjusts to each person's ability, providing gentle assistance during movement. The main goals were to check for side effects and see if patients could stick with the program, with early signs pointing toward improved arm function and reduced spasticity.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
NESM-α exoskeleton (wearable robotic device)
What this could lead to
If successful, this could point toward a practical, personalized robotic therapy to improve arm function and reduce muscle stiffness after a stroke.
What could go wrong
This is a very small pilot study with only 7 participants, so results may not apply to everyone. The device is still experimental and may not provide meaningful improvement over standard therapy.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

7 people

The number who actually took part.

Started

Nov 2024

Finished

Mar 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

18 to 79 years

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion Criteria: * Unilateral ischemic or hemorrhagic stroke, sub-acute (\<6 months) or chronic (\>6 months) * Severe spasticity (MAS ≥ 2) or mild-moderate spasticity with residual active antigravity movements (MAS \< 2) * Fugl-Meyer upper extremity score ≤ 42 * MMSE \> 24 * No severe pain during passive mobilization * Written informed consent Exclusion Criteria: * Unstable clinical conditions * Inability to maintain sitting posture * Pacemaker or other implanted electronic devices * Passive range of motion \< 10°

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Stroke are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Conditions

The condition(s) this trial relates to.

stroke disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Stroke

Contacts and locations

Locations

  • Ospedale Versilia

    Lido di Camaiore, Tuscany, 55041, Italy

More trials for these conditions

Other studies related to the condition(s) this trial covers.